Richard S Geary Ionis Pharmaceuticals Inc (IONS) insider trading activity

Richard S Geary is EVP, Chief Development Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 84,834 shares of IONS, which is worth approximately $2.89 Million. The most recent transaction as insider was on Aug 30, 2024, when has been sold 11 shares (Common Stock) at a price of $38.64 per share, resulting in proceeds of $425. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.8K

0.79% 3M change

16.27% 12M change

Total Value Held $2.89 Million

Richard S Geary Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 30 2024	BUY Other acquisition or disposition	$425 $38.64 p/Share	11 Added 0.01%	84,834 Common Stock
Aug 29 2024	SELL Open market or private sale	$16,427 $49.63 p/Share	331 Reduced 0.39%	84,823 Common Stock
Aug 28 2024	SELL Open market or private sale	$15,731 $49.16 p/Share	320 Reduced 0.37%	85,154 Common Stock
Aug 05 2024	SELL Open market or private sale	$116,640 $48.0 p/Share	2,430 Reduced 2.76%	85,508 Common Stock
Feb 29 2024	BUY Other acquisition or disposition	$20,789 $34.42 p/Share	604 Added 0.68%	87,938 Common Stock
Feb 02 2024	SELL Open market or private sale	$98,128 $50.04 p/Share	1,961 Reduced 2.2%	87,334 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	3,820 Added 4.1%	89,295 Common Stock
Jan 17 2024	SELL Open market or private sale	$369,981 $50.42 p/Share	7,338 Reduced 7.91%	85,475 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	-	19,852 Added 17.62%	92,813 Common Stock
Dec 21 2023	SELL Open market or private sale	$202,680 $49.29 p/Share	4,112 Reduced 5.34%	72,961 Common Stock
Dec 21 2023	BUY Exercise of conversion of derivative security	$194,662 $47.34 p/Share	4,112 Added 5.06%	77,073 Common Stock
Dec 20 2023	SELL Open market or private sale	$322,660 $49.64 p/Share	6,500 Reduced 8.18%	72,961 Common Stock
Dec 20 2023	BUY Exercise of conversion of derivative security	$307,710 $47.34 p/Share	6,500 Added 7.56%	79,461 Common Stock
Dec 14 2023	SELL Open market or private sale	$527,466 $49.7 p/Share	10,613 Reduced 12.7%	72,961 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	$502,419 $47.34 p/Share	10,613 Added 12.11%	77,003 Common Stock
Aug 31 2023	BUY Other acquisition or disposition	$30 $30.56 p/Share	1 Added 0.0%	72,961 Common Stock
Feb 28 2023	BUY Other acquisition or disposition	$17,549 $30.52 p/Share	575 Added 0.78%	72,960 Common Stock
Feb 06 2023	SELL Open market or private sale	$78,067 $40.66 p/Share	1,920 Reduced 2.58%	72,385 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	3,822 Added 4.89%	74,305 Common Stock
Jan 18 2023	SELL Open market or private sale	$311,534 $39.57 p/Share	7,873 Reduced 10.05%	70,483 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	21,983 Added 21.91%	78,356 Common Stock
Feb 28 2022	BUY Other acquisition or disposition	$17,618 $28.37 p/Share	621 Added 1.09%	56,373 Common Stock
Jan 18 2022	SELL Payment of exercise price or tax liability	$229,063 $30.12 p/Share	7,605 Reduced 12.0%	55,752 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	-	21,391 Added 25.24%	63,357 Common Stock
Aug 31 2021	BUY Other acquisition or disposition	$1,555 $33.8 p/Share	46 Added 0.11%	41,966 Common Stock

RSG

Richard S Geary

EVP, Chief Development Officer

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account